Hoffmann-La Roche

Predictive Impact of Circulating Vascular Endothelial Growth Factor in 4 Phase Iii Trials Evaluating Bevacizumab Departments of 1

P. Hegde, A. Jubb, S. Scherer, 2022 .

The Newborn at Risk : Acquired and Congenital Problems

S. Perry, Hoffmann-La Roche, 2005 .

on twin

C. Vervaet, N. Willecke, M. Wunderlich, 2022 .

: Simulating longitudinal differential microbiomeDASim abundance for microbiome data [version 2; peer review: 2 approved

Tom, Paulson, Hoffmann-La Roche, 2020 .

Expression profiles of metabolic enzymes and drug transporters in the liver and along the intestine of beagle dogs

S. Lazic, Dalila Bachir-Cherif, Stefanie D Krämer, 2012 .

THE PRESENT

Hoffmann-La Roche, F.Hoffmann-La, Switzerland Co Ltd Basle, 2019, Pandemic Economics.

Nephrology Dialysis Transplantation Endothelin in renal disease : role of endothelin antagonists

T. Lüscher, R. Wenzel, T. F. Luscher, 2022 .